Centiva Capital’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-20,984
| Closed | -$67.8K | – | 1368 |
|
|
2023
Q4 | $67.8K | Sell |
20,984
-189,016
| -90% | -$611K | ﹤0.01% | 1125 |
|
|
2023
Q3 | $1.12M | Buy |
210,000
+120,000
| +133% | +$637K | 0.02% | 317 |
|
|
2023
Q2 | $858K | Sell |
90,000
-110,000
| -55% | -$1.05M | 0.02% | 362 |
|
|
2023
Q1 | $2.2M | Buy |
+200,000
| New | +$2.2M | 0.05% | 194 |
|
|
2022
Q4 | – | Sell |
-50,000
| Closed | -$956K | – | 932 |
|
|
2022
Q3 | $956K | Buy |
+50,000
| New | +$956K | 0.02% | 354 |
|
|
2022
Q2 | – | Sell |
-25,729
| Closed | -$496K | – | 1219 |
|
|
2022
Q1 | $496K | Buy |
+25,729
| New | +$496K | 0.01% | 605 |
|